Clinical

Dataset Information

Randomized phase II study with UFT capsule /LV or UFT E-granule /LV adjuvant chemotherapy for patients with completely resected high-risk stage II and III colorectal cancer


ABSTRACT: Interventions: UFT capsule / LV for 28 days with 7 days rest for 180days (6months)(1 course=5weeks, 35days). UFT E-granule / LV for 28 days with 7 days rest for 180days (6months)(1 course=5weeks, 35days). Primary outcome(s): treatment complete rate Study Design: Parallel Randomized

DISEASE(S): Colorecrtal Cancer

PROVIDER: 2626356 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR